Clinical Trial Update: Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of Erlotinib in combination with Everolimus (RAD001) for previously treated advanced pancreatic cancer was terminated; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Afinitor (everolimus) (everolimus)
• Tarceva (erlotinib) (erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-09-27